The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (4 analysts) rates it none, with a mean price target of $36.
Rentokil Initial plc
RTO · the NYSE · USD · Market cap $11.3B · 63,388 employees
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific.
FAIL · Does not pass the screenAt the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Rentokil Initial plc holds its Markdown at $22.37. Consolidating, no directional conviction, held for 58 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 58 days |
| Price at the screen | $22.37 |
| Valuation | 35.51 trailing · 14.43 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.41 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 42.47% | Below 33% | Interest-bearing debt is 42.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.01% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 24.04% | Below 49% | Money owed to the company is 24.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.45% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 43.5% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +48% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsPest routes that fail to excite
Think of the van that turns up at your office or home every few months to keep the mice and wasps at bay. That steady, unglamorous work is exactly what Rentokil Initial does across dozens of countries. The service feels essential yet the numbers show only 6 percent revenue growth, a 7 percent profit margin and a 5 percent return on equity.
We pass on the shares. The stock trades at 18.5 times forward earnings with a 15 percent gap to our fair value, but the low returns and unknown competitive edge leave no real margin of safety once you strip away the analyst buy ratings. Ethical screens are cleared, yet that alone does not create an opportunity.
The main risk is that modest growth and thin returns persist in a business where pricing power looks limited and costs can creep up with fuel and labour. A cyclical slowdown in commercial real estate would hit volumes quickly. Analysis, not advice.
| Forward P/E | 14.4xexpensive even after accounting for its growth |
| Trailing P/E | 35.5xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.63 |
| EPS, forward | 1.55 |
| Revenue growth | +6.7%slow but positive growth |
| Profit margin | 6.7%thin but positive margins |
| Return on equity | 6.0%a modest return on shareholder capital |
| FCF yield | 9.33% |
| Dividend yield | 202.00% |
| Debt to equity | 1.11a meaningful debt load worth watching |
| Current ratio | 1.06adequate liquidity, worth monitoring |
| Beta | 0.41barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 22.24 - 34.67 |
| Market cap | $11.3B |
| Employees | 63,388 |
The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeRTO trades on the NYSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (4 analysts) rates it none, with a mean price target of $36.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (4 analysts) rates it none, with a mean price target of $36.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-03 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-08-03 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-05-27 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-05-01 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $33.08 | -8.9% | · | $911 | -8.9% |
| 2 months | $33.60 | -10.3% | · | $897 | -10.3% |
| 3 months | $32.19 | -6.4% | $0.41 | $948 | -5.2% |
| 6 months | $28.83 | +4.5% | $0.41 | $1,059 | +5.9% |
| 1 year | $23.62 | +27.6% | $0.69 | $1,305 | +30.5% |
| 2 years | $25.38 | +18.7% | $1.27 | $1,237 | +23.7% |
| 3 years | $38.03 | -20.8% | $1.83 | $840 | -16.0% |
| 5 years | $31.65 | -4.8% | $2.72 | $1,038 | +3.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RTO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.